Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2021-02-16 4:39 pm Sale | 13G | Vaxcyte Inc. PCVX | RA CAPITAL MANAGEMENT L.P. | 3,710,699 7.3% | -1,778,482 (-32.40%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | PHATHOM PHARMACEUTICALS INC CO PHAT | RA CAPITAL MANAGEMENT L.P. | 3,825,008 12.3% | 178,200 (+4.89%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ZOGENIX INC. ZGNX | RA CAPITAL MANAGEMENT L.P. | 5,345,631 9.6% | 3,084,880 (+136.45%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | SCPHARMACEUTICALS INC SCPH | RA CAPITAL MANAGEMENT L.P. | 3,518,998 12.9% | 271,993 (+8.38%) | View |
| 2021-02-16 4:39 pm Purchase | 13G | BCLS Acquisition Corp. BLSA | RA CAPITAL MANAGEMENT L.P. | 1,250,000 8.4% | 1,250,000 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | 5:01 Acquisition Corp. FVAM | RA CAPITAL MANAGEMENT L.P. | 750,000 8.7% | 750,000 (New Position) | View |
| 2021-02-16 4:39 pm Purchase | 13G | ARS Pharmaceuticals Inc. SPRY | RA CAPITAL MANAGEMENT L.P. | 1,742,186 5% | 1,742,186 (New Position) | View |
| 2021-02-16 4:34 pm Purchase | 13G | Verona Pharma plc VRNA | RA CAPITAL MANAGEMENT L.P. | 41,543,004 9.99% | 41,543,004 (New Position) | View |
| 2021-02-11 4:46 pm Sale | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | RA CAPITAL MANAGEMENT L.P. | 0 0% | -13,730,376 (Position Closed) | View |
| 2021-02-10 4:49 pm Sale | 13G | TG THERAPEUTICS, INC. TGTX | RA CAPITAL MANAGEMENT L.P. | 6,361,123 4.7% | -2,324,348 (-26.76%) | View |
| 2021-02-10 4:48 pm Sale | 13G | KEROS THERAPEUTICS INC KROS | RA CAPITAL MANAGEMENT L.P. | 0 0% | -1,875,000 (Position Closed) | View |
| 2021-02-10 4:47 pm Sale | 13G | ARVINAS INC ARVN | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,672,872 (Position Closed) | View |
| 2021-02-10 4:46 pm Sale | 13G | CARDIFF ONCOLOGY INC CRDF | RA CAPITAL MANAGEMENT L.P. | 0 0% | -3,290,000 (Position Closed) | View |
| 2021-02-10 4:34 pm Sale | 13G | TG THERAPEUTICS, INC. TGTX | RA CAPITAL MANAGEMENT L.P. | 8,685,471 6.4% | -4,102,986 (-32.08%) | View |
| 2021-02-10 4:31 pm Purchase | 13G | KEROS THERAPEUTICS INC KROS | RA CAPITAL MANAGEMENT L.P. | 1,875,000 8.1% | 1,875,000 (New Position) | View |
| 2021-02-08 5:16 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | RA CAPITAL MANAGEMENT L.P. | 13,730,376 10.6% | 3,730,376 (+37.30%) | View |
| 2021-01-29 4:30 pm Purchase | 13G | CytomX Therapeutics Inc. CTMX | RA CAPITAL MANAGEMENT L.P. | 3,500,000 5.8% | 3,500,000 (New Position) | View |
| 2020-12-17 4:40 pm Purchase | 13G | VIRIDIAN THERAPEUTICS INC VRDN | RA CAPITAL MANAGEMENT L.P. | 451,932 11.6% | 451,932 (New Position) | View |
| 2020-12-16 5:24 pm Purchase | 13D | Solid Biosciences Inc. SLDB | RA CAPITAL MANAGEMENT L.P. | 9,976,569 11.8% | 5,405,405 (+118.25%) | View |
| 2020-12-02 4:31 pm Purchase | 13G | ITERUM THERAPEUTICS PLC SHS NE ITRM | RA CAPITAL MANAGEMENT L.P. | 10,000,000 18.9% | 10,000,000 (New Position) | View |